Brain repair: Experimental treatment strategies, neuroprotective and repair strategies in the lesioned adult CNS

Advances in Experimental Medicine and Biology

Volumn 557, Issue , 2005, Pages 148-163

  Bähr, Mathias ^a   Lingor, Paul ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; ADENOSINE; APTIGANEL; ARGININE; BRADYKININ; CALCIUM; CASPASE; CASPASE 3 INHIBITOR; CASPASE INHIBITOR; DEXTRORPHAN; DIZOCILPINE; DOUBLE STRANDED RNA; ELIPRODIL; EXCITATORY AMINO ACID; GLUTAMIC ACID; LOBRADIMIL; LUBELUZOLE; LYSINE; MANNITOL; MEMBRANE RECEPTOR; NEUROTROPHIC FACTOR; NIMODIPINE; PLACEBO; PROTEIN BCL 2; SIPATRIGINE; VIRUS VECTOR; WORTMANNIN;

APOPTOSIS; BLOOD BRAIN BARRIER; CELL DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM METASTASIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG RECEPTOR BINDING; GENE SILENCING; GENE TRANSFER; GLIOMA; HUMAN; HYPERTENSION; HYPOTENSION; META ANALYSIS; MITOCHONDRION; NERVE FIBER TRANSECTION; NEUROPROTECTION; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; ONTOGENY; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; RETINA INJURY; RETINOTECTAL PROJECTION; REVIEW; RNA INTERFERENCE; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; APOPTOSIS; BLOOD-BRAIN BARRIER; CALCIUM; CASPASES; CENTRAL NERVOUS SYSTEM; EXCITATORY AMINO ACIDS; GENE TRANSFER TECHNIQUES; HUMANS; MORPHOGENESIS; NERVE GROWTH FACTORS; OPTIC NERVE; PROTO-ONCOGENE PROTEINS C-BCL-2; REGENERATION; RETINA; SUPERIOR COLLICULUS; TISSUE TRANSPLANTATION; VISUAL PATHWAYS;

EID: 33744521770     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (80)

1. Lund RD, Land PW, Boles J. Normal and abnormal uncrossed retinotectal pathways in rats: An HRP study in adults. J Comp Neurol 1980; 189(4):711-20.
2. Beckstead RM, Frankfurter A. A direct projection from the retina to the intermediate gray layer of the superior colliculus demonstrated by anterograde transport of horseradish peroxidase in monkey, cat and rat. Exp Brain Res 1983; 52(2):261-8.
3. Dreher B, Sefton AJ, Ni SY et al. The morphology, number, distribution and central projections of Class I retinal ganglion cells in albino and hooded rats. Brain Behav Evol 1985; 26(1):10-48.
4. Cellerino A, Bahr M, Isenmann S. Apoptosis in the developing visual system. Cell Tissue Res Jul 2000; 301(1):53-69.
5. Kermer P, Klocker N, Weishaupt JH et al. Transection of the optic nerve in rats: Studying neuronal death and survival in vivo. Brain Res Brain Res Protoc 2001; 7(3):255-60.
6. Kerr FR, Wyllie AM, Currie AR. Apoptosis: A basic biological phenomenon with wider ranging implications in tissue kinetics. Br J Cancer 1972; 24:239-275.
7. Potts RA, Dreher B, Bennett MR. The loss of ganglion cells in the developing retina of the rat. Brain Res 1982; 255(3):481-6.
8. Galli-Resta L, Ensini M. An intrinsic time limit between genesis and death of individual neurons in the developing retinal ganglion cell layer. J Neurosci 1996; 16(7):2318-24.
9. Burek MJ, Oppenheim RW. Programmed cell death in the developing nervous system. Brain Pathol 1996; 6(4):427-46.
10. Gupta S, Barrett T, Whitmarsh AJ et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996; 15(11):2760-70.
11. Hüll M, Bähr M. Differential regulation of c-JUN expression in rat retinal ganglion cells after proximal and distal optic nerve transection. Neurosci Lett 1994; 178(1):39-42.
12. Estus S, Zaks WJ, Freeman RS et al. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 1994; 127:1717-27.
13. Crocker SJ, Lamba WR, Smith PD et al. c-Jun mediates axotomy-induced dopamine neuron death in vivo. Proc Natl Acad Sci USA 2001; 98(23):13385-90.
14. Martin-Villalba A, Winter C, Brecht S et al. Rapid and long-lasting suppression of the ATF-2 transcription factor is a common response to neuronal injury. Brain Res Mol Brain Res 1998; 62(2):158-66.
15. Roffler-Tarlov S, Brown JJ, Tarlov E et al. Programmed cell death in the absence of c-Fos and c-Jun. Development 1996; 122(1):1-9.
16. Sulston JE, Horvitz HR. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol 1977; 56(1):110-56.
17. Kuida K, Zheng TS, Na S et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature Nov 28 1996 ; 384(6607):368-72.
18. Kermer P, Klocker N, Labes M et al. Activation of caspase-3 in axotomized rat retinal ganglion cells in vivo. FEBS Lett 1999; 453(3):361-4.
19. Kermer P, Ankerhold R, Klocker N et al. Caspase-9: Involvement in secondary death of axotomized rat retinal ganglion cells in vivo. Brain Res Mol Brain Res 2000; 85(1-2}:144-50.
20. Schulze-Osthoff K, Ferrari D, Los M et al. Apoptosis signaling by death receptors. Eur J Biochem 1998; 254(3):439-59.
21. Varfolomeev EE, Schuchmann M, Luria V et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apol, and DR3 and is lethal prenatally. Immunity 1998; 90:267-76.
22. Plesnila N, Zinkel S, Le DA et al. BID mediates neuronal cell death after oxygen/glucose deprivation and focal cerebral ischemia. Proc Natl Acad Sci USA 2001; 98(26):15318-23.
23. Alnemri ES, Livingston DJ, Nicholson DW et al. Human ICE/CED-3 protease nomenclature. Cell 1996; 87(2):171.
24. Schuler M, Green DR. Mechanisms of p53-dependent apoptosis. Biochem Soc Trans 2001; 29:684-8.
25. Reed JC. Bcl-2 family proteins. Oncogene 1998; 17(25):3225-36.
26. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281(5381):1309-12.
27. Lindenboim L, Borner C, Stein R. Bcl-x(S) can form homodimers and heterodimers and its apoptotic activity requires localization of Bcl-x(S) to the mitochondria and its BH3 and loop domains. Cell Death Differ 2001; 8(9):933-42.
28. Schendel SL, Montal M, Reed JC. Bcl-2 family proteins as ion-channels. Cell Death Differ 1998; 5(5):372-80.
29. Vander Heiden MG, Thompson CB. Bcl-2 proteins: Regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1999; 1(8):E209-16.
30. Martinou JC. Apoptosis. Key to the mitochondrial gate. Nature 1999; 399(6735):411-2.
31. Newmeyer DD, Bossy-Wetzel E, Kluck RM et al. Bcl-xL does not inhibit the function of Apaf-1. Cell Death Differ 2000; 7(4):402-7.
32. Veis DJ, Sorenson CM, Shutter JR et al. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993; 75(2):229-40.
33. Motoyama N, Wang F, Roth KA et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995; 267(5203):1506-10.
34. Brady HJ, Gil-Gomez G. Bax. The pro-apoptotic Bcl-2 family member, Bax. Int J Biochem Cell Biol 1998; 30(6):647-50.
35. Korsmeyer SJ, Wei MC, Saito M et al. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 2000; 7(12):1166-73.
36. Isenmann S, Wahl C, Krajewski S et al. Up-regulation of Bax protein in degenerating retinal ganglion cells precedes apoptotic cell death after optic nerve lesion in the rat. Eur J Neurosci 1997; 9(8):1763-72.
37. Yin XM. Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res 2000; 10(3):161-7.
38. Antonsson B. Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion. Cell Tissue Res 2001 Dec; 306(3):34/-61.
39. Diem R, Meyer R, Weishaupt JH et al. Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo. J Neurosci 2001; 21(6):2058-66.
40. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1(8):623-634.
41. Ermak G, Davies KJ. Calcium and oxidative stress: From cell signaling to cell death. Mol Immunol 2002; 38(10):713-21.
42. Cellerino A, Galli-Resta L, Colombaioni L. The dynamics of neuronal death: A time-lapse study in the retina. J Neurosci 2000; 20(16):RC92.
43. Chaudhary P, Ahmed F, Quebada P et al. Caspase inhibitors block the retinal ganglion cell death following optic nerve transection. Brain Res Mol Brain Res 1999; 67(1):36-45.
44. Kermer P, Klocker N, Bahr M. Long-term effect of inhibition of ced 3-like caspases on the survival ofaxotomized retinal ganglion cells in vivo. Exp Neurol 1999 Jul; 158(1):202-5.
45. Oppenheim RW. The concept of uptake and retrograde transport of neurotrophic molecules during development: History and present status. Neurochem Res 1996; 21(7):769-77.
46. Johnson D, Lanahan A, Buck CR et al. Expression and structure of the human NGF receptor. Cell 1986; 47(4):545-54.
47. Niederhauser O, Mangold M, Schubenel R et al. NGF ligand alters NGF signaling via p75(NTR) and trkA. J Neurosci Res 2000; 61(3):263-72.
48. Frade JM, Rodriguez-Tebar A, Barde YA. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 1996; 383(6596):166-8.
49. Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982; 1(5):549-53.
50. Cohen-Cory S, Fraser SE. Effects of brain-derived neurotrophic factor on optic axon branching and remodelling in vivo. Nature 1995; 378(6553):192-6.
51. Mey J, Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res 1993; 602(2):304-17.
52. Peinado-Ramon P, Salvador M, Villegas-Perez MP et al. Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. A quantitative in vivo study. Invest Ophthalmol Vis Sci 1996; 37(4):489-500.
53. Kermer P, Klöcker N, Labes M et al. Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 In vivo. J Neurosci 2000; 20:2-8.
54. Cellerino A, Bahr M, Isenmann S. Apoptosis in the developing visual system. Cell Tissue Res 2000; 301(1):53-69.
55. Gandolfo C, Sandercock P, Conti M. Lubeluzole for acute ischaemic stroke. Cochrane Database Syst Rev 2002; (1):CD001924.
56. Schmitt U, Sabel BA. MK-801 reduces retinal ganglion cell survival but improves visual performance after controlled optic nerve crush. J Neurotrauma 1996; 13(12):791-800.
57. Horn J, de Haan RJ, Vermeulen M et al. Very early nimodipine use in stroke (VENUS): A randomized, double-blind, placebo-controlled trial. Stroke 2001; 32(2):461-5.
58. Mayhan WG. Regulation of blood-brain barrier permeability. Microcirculation 2001; 8(2):89-104.
59. Emerich DF, Dean RL, Osborn C et al. The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: From concept to clinical evaluation. Clin Pharmacokinet 2001; 40(2):105-23.
60. Kordower JH, Goetz CG, Freeman TB et al. Dopaminergic transplants in patients with Parkinson's disease: Neuroanatomical correlates of clinical recovery. Exp Neurol 1997; 144(1):41-6.
61. Freed CR. Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease? Proc Natl Acad Sci USA 2002; 99(4):1755-7.
62. Kugler S, Meyn L, Holzmuller H et al. Neuron-specific expression of therapeutic proteins: Evaluation of different cellular promoters in recombinant adenoviral vectors. Mol Cell Neurosci 2001; 17(1):78-96.
63. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89(12):5547-51.
64. Hellen CU, Sarnow P. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 2001; 15(13):1593-612.
65. Hitt MM, Addison CL, Graham FL. Human adenovirus vectors for gene transfer into mammalian cells. Adv Pharmacol 1997; 40:137-206.
66. Schmeer C, Strafen G, Kugler S et al. Dose-dependent rescue of axotomized rat retinal ganglion cells by adenovirus-mediated expression of glial cell-line derived neurotrophic factor in vivo. Eur J Neurosci 2002; 15(4):637-43.
67. Kugler S, Klocker N, Kermer P et al. Transduction of axotomized retinal ganglion cells by adenoviral vector administration at the optic nerve stump: An in vivo model system for the inhibition of neuronal apoptotic cell death. Gene Ther 1999; 6(10):1759-67.
68. Kugler S, Straten G, Kreppel F et al. The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo. Cell Death Differ 2000; 7(9):815-24.
69. Lundstrom K, Schweitzer C, Rotmann D et al. Semliki Forest virus vectors: Efficient vehicles for in vitro and in vivo gene delivery. FEBS Lett 2001; 504(3):99-103.
70. Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 1988; 55(6):1179-88.
71. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988; 55(6):1189-93.
72. Joliot A, Pernelle C, Deagostini-Bazin H et al. Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci USA 1991; 88(5):1864-8.
73. Elliott G, O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 1997; 88(2):223-33.
74. Schwarze SR, Ho A, Vocero-Akbani A et al. In vivo protein transduction: Delivery of a biologically active protein into the mouse. Science 1999; 285(5433):1569-72.
75. Vocero-Akbani AM, Heyden NV, Lissy NA et al. Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat Med 1999; 5(1):29-33.
76. Caplen NJ, Parrish S, Imani F et al. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA. 2001; 98(17):9742-7.
77. Clemens MJ, Elia A. The double-stranded RNA-dependent protein kinase PKR: Structure and function. J Interferon Cytokine Res 1997; 17(9):503-24.
78. Nicholson RH, Nicholson AW. Molecular characterization of a mouse cDNA encoding Dicer, a ribonuclease III ortholog involved in RNA interference. Mamm Genome 2002; 13(2):67-73.
79. Caplen NJ. A new approach to the inhibition of gene expression. Trends Biotechnol 2002; 20(2):49-51.
80. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296(5567):550-3.